ViaCyte proposes stem cell implant to address type 1 diabetes

05/31/2011 | Los Angeles Times (tiered subscription model)

San Diego-based ViaCyte has proposed implanting a pouch filled with pancreatic cells under the skin to help reduce insulin dependence among patients with type 1 diabetes. The firm tested the procedure to treat diabetes in mice and hopes to initiate human trials in patients by 2013.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD